ANI Pharmaceuticals (ANIP)
(Delayed Data from NSDQ)
$60.36 USD
-1.30 (-2.11%)
Updated May 23, 2024 04:00 PM ET
After-Market: $60.16 -0.20 (-0.33%) 5:24 PM ET
4-Sell of 5 4
B Value A Growth C Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/14/24 |
---|---|
Current Quarter | 0.94 |
EPS Last Quarter | 1.21 |
Last EPS Surprise | 23.47% |
ABR | 1.20 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.48 |
Next Year | 5.04 |
EPS (TTM) | 4.76 |
P/E (F1) | 13.76 |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 128.24M | 134.90M | 540.70M | 578.99M |
# of Estimates | 4 | 4 | 4 | 4 |
High Estimate | 130.60M | 135.33M | 543.06M | 586.09M |
Low Estimate | 126.00M | 134.40M | 538.00M | 566.08M |
Year ago Sales | 116.55M | 131.83M | 486.82M | 540.70M |
Year over Year Growth Est. | 10.03% | 2.32% | 11.07% | 7.08% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.94 | 1.10 | 4.48 | 5.04 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | 0.88 | 1.12 | 4.51 | 5.18 |
High Estimate | 0.98 | 1.14 | 4.62 | 5.34 |
Low Estimate | 0.88 | 1.03 | 4.30 | 4.52 |
Year ago EPS | 1.28 | 1.27 | 4.71 | 4.48 |
Year over Year Growth Est. | -26.56% | -13.39% | -4.88% | 12.44% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 3 | 1 |
Up Last 60 Days | 0 | 0 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 4 | 1 | 2 |
Down Last 60 Days | 4 | 4 | 1 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.94 | 1.10 | 4.48 | 5.04 |
7 Days Ago | 0.94 | 1.10 | 4.48 | 5.04 |
30 Days Ago | 1.06 | 1.17 | 4.43 | 5.04 |
60 Days Ago | 1.06 | 1.17 | 4.43 | 5.04 |
90 Days Ago | 0.99 | 1.15 | 4.12 | 4.80 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.94 | 1.10 | 4.48 | 5.01 |
Zacks Consensus Estimate | 0.94 | 1.10 | 4.48 | 5.04 |
Earnings ESP | 0.00% | 0.00% | 0.00% | -0.48% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 1.21 | 1.00 | 1.27 | 1.28 | NA |
Estimate | 0.98 | 0.80 | 0.76 | 0.64 | NA |
Difference | 0.23 | 0.20 | 0.51 | 0.64 | 0.40 |
Surprise | 23.47% | 25.00% | 67.11% | 100.00% | 53.90% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more